In spring 2023, a 33-year-old male patient diagnosed with acute respiratory distress syndrome (ARDS) was admitted to Northwestern Memorial Hospital in the United States. The patient’s condition escalated into necrotizing pneumonia and overwhelming sepsis. Despite being placed on a ventilator, his condition kept deteriorating, and he had to face renal failure and cardiac arrest as a consequence.
Facing the rare clinical dilemma, the medical team led by thoracic surgeon Dr. Ankit Bharat at Northwestern University Feinberg School of Medicine in Chicago decided to support the patient with a newly developed artificial lung system, after removing the patient’s infected lungs.
The patient’s condition began to improve within just 48 hours. Bharat observed that the man’s kidney function was completely restored and his heart returned to normal. He no longer required any medication to support his blood pressure. The patient later received a successful double lung transplant and has not experienced any signs of organ rejection or impaired lung function to this day.
Dr. Natasha Rogers, a transplant clinician at Westmead Hospital in Sydney, Australia, commented that the engineering behind the artificial lung system is remarkable and the team involved was “very brave.”
Dr. Bharat expressed hope that such life-saving technology would be increasingly accessible for critically ill patients awaiting lung transplants. However, Rogers emphasized that implementing this approach requires multiple specialized teams, because only large hospitals would be capable of deploying it. Therefore, the application of this system remains limited.
The Bank Group’s contribution includes $24.64 million from the African Development Fund, its concessional lending arm, and an additional $5.21 million from the AfDB. The remaining funds will come from the Government of Rwanda.
The project will expand and upgrade the Centre of Excellence, located in Kigali Innovation City, a growing tech hub in the Rwandan capital. Plans include enhanced academic programs and student training, new laboratories and facilities, advanced equipment procurement, and stronger linkages with the private sector.
Phase II will train 470 students in biomedical engineering, rehabilitation and mobility sciences, and digital health at bachelor’s and master’s levels, with most beneficiaries coming from Rwanda and other East African Community countries. The project will also provide PhD and post-doctoral training for University of Rwanda staff to ensure high-quality teaching and research.
In addition, the project will support curriculum reform, accreditation, and collaborative research with leading international institutions. Regional integration will be promoted through student and faculty exchanges, joint research initiatives, knowledge-sharing events, and entrepreneurship support programs.
A notable innovation under Phase II is the establishment of a Biomedical Innovation Park, which will allow students, researchers, and private companies to design, test, and produce health technologies tailored to local and regional needs.
The project is expected to benefit the wider community by providing hospitals and clinics with locally trained specialists capable of installing, maintaining, and repairing medical equipment. Expanded access to digital health tools and telemedicine will also make healthcare more accessible, particularly in rural areas.
During its construction phase, the project will create hundreds of temporary jobs, mainly for young people. In the long term, it is expected to stimulate the development of health technology businesses, attract research funding, and create skilled employment opportunities.
“This project will equip our young people with world-class skills while bringing better health services closer to families. It is an investment in talent, innovation, and the wellbeing of our communities,” said Hendrina Doroba, AfDB Manager for Education and Skills Development.
Following approval on January 9, the project will be implemented by the Government of Rwanda through the University of Rwanda and is scheduled to run through 2030. It supports Rwanda’s long-term vision of building a knowledge-driven economy and a resilient, inclusive health system.
Modelling shows extreme weather disruptions could drive 79 percent of additional malaria cases and 93 percent of deaths across Africa by 2050, mainly from floods and cyclones damaging homes, bednets and health services, said a statement of The Kids Research Institute Australia on Thursday.
The study, published in Nature on Wednesday by the institute and Australia’s Curtin University, analyzed 25 years of data on climate, malaria burden, control interventions, socioeconomic indicators, and extreme weather patterns across Africa.
Most previous studies focused on climate change’s direct effects on mosquitoes and parasites, said study lead author, Associate Professor Tasmin Symons, a member of the Malaria Atlas Project, a research group based at the institute.
This research shows extreme weather poses the greatest threat to malaria control by repeatedly damaging housing, health services and interventions that suppress transmission, Symons said.
“While changes in transmission ecology are real, they are comparatively small. When those changes are combined with repeated disruption to malaria control, the impacts become substantial,” she said.
Researchers urge embedding climate resilience into malaria policies and health planning to sustain progress toward eradication.
Appearing before the Committee on Governance and Gender Affairs on Tuesday, Minister of State in the Ministry of Health Dr. Yvan Butera said that the prevalence had dropped from 20.5% in 2018 to 18.6% in 2025.
“The preliminary figures show a decrease, which we attribute to the increasing efforts and resources dedicated to mental health services,” Dr. Butera said.
According to the ministry, mental health problems linked to depression fell from 11.9% in 2018 to 9.1% last year, while cases associated with stress decreased from 8% to 3%. However, conditions related to alcohol and drug use rose from 1.6% to 2.4%.
Other mental health conditions include schizophrenia (3%), bipolar disorder (0.4%), suicidal thoughts (0.9%), and substance use disorders (0.8%).
Dr. Butera noted that support programs for survivors of the 1994 Genocide against the Tutsi, their descendants, and school-based mental health initiatives have contributed to the overall decline, even as challenges remain.
He identified three major factors driving mental health issues in Rwanda: depression linked to the country’s historical trauma, stress, and substance abuse.
“Depression has decreased from 11.9% in 2018 to 9.1%, stress from 8% to 3%, while alcohol and drug use has increased slightly from 1.6% to 2.4%,” he explained.
The ministry’s data also highlights age-related trends. Adults aged 46–55 represent the largest group affected (25%), followed by those aged 36–45 (24%) and 56–65 (23.6%). Among younger people, 26–35-year-olds account for 18.2%, 19–25-year-olds for 13.7%, and 14–18-year-olds for 8.7%.
Rwanda’s mental health services are anchored at the community level, with approximately 60,000 health advisors across the country. Specialised hospitals provide more advanced care, and 80% of health centres now offer at least some mental health services.
Access to medication has also improved, with 14 types of drugs available at health centers and 20 at hospitals. The country has also launched a specialized clinic for severe depression and suicidal tendencies, known as the “Ketamine Clinic,” at King Faisal Hospital.
In response to concerns from Deputy Mukayiranga Muyango Sylvie about potential risks of using ketamine, Dr. Gishoma Darius, manager of the Mental Health Division at the Rwanda Biomedical Centre, explained that although ketamine was initially used in veterinary medicine, it has been safely used in mental health treatment for the past 20 years.
He noted that research shows it can be effective for patients who have attempted suicide multiple times and do not respond to conventional medication, and that its use is closely monitored.
The decision was announced on Thursday in a joint statement by US Health Secretary Robert F Kennedy Jr and Secretary of State Marco Rubio, who cited what they described as the WHO’s failures during the COVID-19 pandemic.
They said US engagement with the organisation will now be limited to finalising withdrawal procedures and protecting the health and safety of Americans, adding that all US funding to the WHO has stopped.
The move follows President Donald Trump’s announcement on January 20, 2025, the first day of his second term, that the US would leave the Geneva-based agency.
UN Spokesperson Stephane Dujarric confirmed that the US is no longer participating in the WHO’s work, although some legal and administrative details remain unresolved. He said the UN would welcome a full return of the US, stressing that global health threats such as pandemics and non-communicable diseases require international cooperation.
WHO Director-General Tedros Adhanom Ghebreyesus previously said the organisation has already made budget cuts to manage funding shortfalls linked to the US exit.
The WHO’s chief legal officer, Steven Solomon, noted that the organisation’s founders had not originally included a withdrawal clause, viewing it as a universal body essential to global safety.
Public health experts have criticised the US decision. Health advocate Lucky Tran said the WHO has played a critical role in reducing disease and saving lives worldwide, warning that withdrawal weakens collective responses to global health threats.
Before the US exit, the WHO had 194 member states and has long coordinated international responses to health emergencies, including disease outbreaks and humanitarian crises across borders.
The partnership, dubbed Horizon1000, aims to support several African countries in deploying AI tools to improve healthcare delivery, starting with Rwanda. Bill Gates announced the initiative on Wednesday, saying AI could help address severe shortages of health workers and weak health system infrastructure in low-income countries.
“In poorer countries with enormous health worker shortages and lack of health systems infrastructure, AI can be a gamechanger in expanding access to quality care,” Gates said in a blog post announcing the launch.
Speaking to Reuters on the sidelines of the World Economic Forum in Davos, Gates said the initiative comes at a critical time, after international aid cuts last year were followed by the first rise in preventable child deaths this century.
{{Aid cuts and pressure on health systems
}}
International aid reductions began with the United States at the start of 2025 and later spread to other major donors, including Britain and Germany. Overall, global development assistance for health fell by nearly 27% last year compared to 2024, according to estimates by the Gates Foundation.
Gates said AI could help countries cope with the impact of these cuts by improving efficiency and quality of care.
“Using innovation, using AI, I think we can get back on track,” he told Reuters, adding that the technology would revolutionise healthcare. “Our commitment is that that revolution will at least happen in the poor countries as quickly as it happens in the rich countries.”
{{Rwanda’s growing AI health role
}}
Rwanda was chosen in part because of its early investments in digital health and AI. Last year, the country established an AI health hub in Kigali, and recently launched an AI-powered Health Intelligence Center under its health sector reforms.
Rwanda is accelerating efforts to strengthen its health workforce through the 4×4 health sector strategy, launched in 2023 to quadruple the number of trained healthcare professionals within four years. With about one healthcare worker per 1,000 people, below the WHO recommendation of four per 1,000, officials say AI and other innovations will play a crucial role in expanding access and improving care quality nationwide.
“As part of the Horizon1000 initiative, we aim to accelerate the adoption of AI tools across primary care clinics, within communities, and in people’s homes,” Gates said, stressing that the technology is intended to support health workers, not replace them.
Paula Ingabire, Rwanda’s minister of information and communications technology and innovation, said the focus would be on responsible use of AI to ease pressure on frontline staff.
“It is about using AI responsibly to reduce the burden on healthcare workers, to improve the quality of care, and to reach more patients,” she said.
Horizon1000 aims to reach 1,000 primary healthcare clinics and surrounding communities across several countries by 2028, through a mix of funding, technology, and technical support.
Gates said the initiative would likely prioritise care for pregnant women and people living with HIV, including providing AI-powered advice before patients reach clinics, particularly for those facing language barriers. Once at the clinic, AI tools could help reduce paperwork, link patient histories, and streamline appointments.
“A typical visit, we think, can be about twice as fast and much better quality,” Gates said.
Data from the National Institute of Statistics of Rwanda (NISR) reveal that, between 2019 and 2024, a total of 54,287 people in Rwanda were diagnosed with HIV. The highest numbers were recorded in the City of Kigali and the Western Province.
In 2024 alone, 9,019 people tested positive for HIV, including 3,503 men and 5,516 women, out of 1,026,851 individuals tested that year. In 2023, more than 1.1 million people were tested, with 9,270 positive cases (3,752 men and 5,518 women), marking a slight increase from 2022, when 8,507 people tested positive (3,404 men and 5,103 women) from over 1.1 million tests. In 2021, 9,422 people were diagnosed, comprising 3,673 men and 5,749 women from more than 1.5 million tests.
In 2020, 9,279 people tested positive out of over 2.09 million tests, including 3,577 men and 5,702 women. This was an increase compared to 2019, when 8,790 people were diagnosed (4,040 men and 4,750 women) from 2.6 million tests.
{{Kigali and Eastern Province most affected
}}
The City of Kigali continues to record the highest number of HIV cases in the country. In 2024, 2,883 residents tested positive, compared to 2,811 in 2023 and 2,756 in 2022. Previous years saw 2,983 cases in 2021, 3,136 in 2020, and 3,707 in 2019.
The Eastern Province follows Kigali in new infections. In 2024, 2,439 people tested positive, compared with 2,675 in 2023 and 2022, 2,398 in 2020, and 2,676 in 2019.
The Southern Province also reported significant numbers, with 1,573 positive cases in 2024, compared to 1,543 in 2023, 1,420 in 2022, 1,589 in 2021, 1,665 in 2020, and 1,045 in 2019.
In the Western Province, 1,257 people were diagnosed in 2024, compared to 1,431 in 2023, 1,400 in 2022, 2,460 in 2021, 1,319 in 2020, and 852 in 2019. The Northern Province recorded 867 new cases in 2024, compared with 810 in 2023, 728 in 2022, 932 in 2021, 761 in 2020, and 510 in 2019.
{{Age and gender trends
}}
Over the six-year period, most HIV diagnoses were among people over 25 years old, totaling 41,385 cases, followed by young people aged 15 to 24, who accounted for 11,234 cases. Among pregnant women, 1,221 were living with HIV in 2024, up from 1,141 in 2023, while earlier years recorded 1,420 in 2022, 1,625 in 2021, 1,314 in 2020, and 1,831 in 2019.
In 2024, 5,570 women living with HIV were receiving antiretroviral therapy, representing 99.0% coverage. That year, 67,761 couples were tested, with 3,350 found to be discordant, meaning one partner was HIV positive while the other was not.
{{National HIV landscape
}}
As of December 2025, the Rwanda Biomedical Centre (RBC) reported that 234,000 people were living with HIV in the country. HIV-related deaths are estimated at around 2,500 annually, while new infections among people aged 15 to 49 stood at 2.7%.
Rwanda has achieved and surpassed the United Nations 95-95-95 targets, which aim for 95% of people living with HIV to know their status, 95% of those diagnosed to be on treatment, and 95% of those on treatment to achieve viral suppression. The country currently stands at 96-98-98.
The Ministry of Health notes that strong investment in HIV care is yielding positive results. In 2025, people aged 50 and above accounted for 30% of all individuals living with HIV, reflecting improved life expectancy among patients.
The figures, based on records from the Rwanda Biomedical Centre (RBC), show that 4,219 women underwent the procedure in 2024 alone, reflecting a steady increase in uptake over the past five years.
{{Family planning trends in Rwanda
}}
Family planning use in Rwanda continues to rise, with the number of continuing users increasing from 1.57 million in 2019 to 2.06 million by the end of December 2024. Over the same period, hundreds of thousands of new users joined family planning programs each year, highlighting sustained demand for reproductive health services.
Among modern contraceptive methods, implants remain the most popular, with 879,113 continuing users by the end of 2024, up from 571,510 in 2019. In 2024 alone, 212,974 women newly adopted implants, making it the leading method both in uptake and total use.
Injectable contraceptives, mainly Depo-Provera and Noristerat, rank second, with 671,008 continuing users at the end of 2024, including 180,182 new users during the year. Oral contraceptive pills recorded 348,291 continuing users, with 141,205 new users added during the year.
The use of hormonal intrauterine devices (IUDs) also increased, reaching 51,630 continuing users, including 11,990 new users in 2024. Despite the dominance of modern methods, 25,705 people still rely on traditional family planning approaches, such as cycle beads, lactational amenorrhea method (LAM), and auto-observation, which do not require medical procedures or pharmaceutical products.
{{Women embrace permanent contraception
}}
The number of women opting for tubal ligation has risen sharply over time in Rwanda. Tubal ligation is a surgical procedure in which a woman’s fallopian tubes are blocked, tied, or cut to prevent eggs from reaching the uterus, thereby eliminating the possibility of fertilisation.
Records show 14,456 continuing users in 2019, increasing to 18,350 in 2020, 20,904 in 2021, 26,285 in 2022, 31,439 in 2023, and finally 35,105 by the end of 2024. This consistent growth suggests increasing acceptance of long-term reproductive decisions, particularly among women who have completed their desired family size.
{{Low male Participation in permanent contraception
}}
Meanwhile, male involvement in permanent family planning remains limited. By the end of 2024, only 4,432 men had undergone vasectomy, with only 121 procedures recorded during the year. Vasectomy remains the only permanent family planning method available to men and involves blocking the ducts that carry sperm from the testes, preventing fertilisation.
Family planning remains a cornerstone of Rwanda’s strategy to manage population growth, reduce poverty, and improve health outcomes. NISR data show that Rwanda’s population growth rate stood at 2.3% between 2012 and 2022, and projections indicate the population could rise from just over 14.1 million today to more than 22 million by 2050, while the country’s land area remains unchanged.
The average fertility rate for Rwandan women is estimated at 3.6 children per woman, which is significantly higher than the global average fertility rate of 2.3 children per woman. This underscores the importance of sustained investment in reproductive health services.
According to the Rwanda Biomedical Centre (RBC), the new intervention ensures that every baby born in Rwanda receives a dose of the Hepatitis B vaccine within 24 hours of birth, a critical window for preventing mother-to-child transmission of the virus.
Hepatitis B is a highly infectious viral disease that can be passed from an infected mother to her child during childbirth. Health experts warn that when infection occurs at birth, up to 95 per cent of affected infants go on to develop chronic Hepatitis B, significantly increasing their risk of liver cirrhosis and liver cancer later in life. The birth dose vaccine is widely recognised as the most effective and cost-efficient way to prevent such transmission.
Globally, an estimated 296 million people are living with chronic Hepatitis B, while viral hepatitis causes more than one million deaths each year, largely due to liver cancer and cirrhosis.
RBC noted that the country has already made notable progress in hepatitis prevention and control through strong immunisation systems, widespread screening and free access to treatment. National data indicate a low Hepatitis B prevalence of approximately 0.26 per cent, reflecting the impact of sustained public health interventions.
“Introduction of the universal birth dose further strengthens Rwanda’s commitment to eliminating viral hepatitis as a public health threat by 2030,” the centre said in a statement on Friday, January 2, 2026.
To support the rollout, health facilities across the country have been equipped to administer the vaccine within 24 hours of birth, including for babies born outside health facilities. Health workers have also received targeted training, while cold chain systems have been strengthened to ensure vaccine safety and consistent availability.
RBC has called on health workers, parents, communities and partners to support the initiative by ensuring that all newborns receive the Hepatitis B birth dose on time.
The centre said the new measure underscores the importance of vaccination in safeguarding public health, emphasising that vaccines save lives and remain a cornerstone of disease prevention.
Among the major advances are kidney transplants, introduced locally in 2023, and advanced cardiac surgery. Both services are now routinely offered at King Faisal Hospital (KFH), Rwanda, underscoring the country’s steady progress in specialised care.
According to Dr. Augustin Sendegeya, the Chief Medical Officer at KFH Rwanda, a total of 88 kidney transplants were performed in 2025. During the same period, 861 heart surgeries were conducted, including 543 procedures on children and 318 on adults.
Kidney transplantation is among the most complex medical services globally, typically available only in highly advanced healthcare systems. Its availability in Rwanda reflects more than three decades of progress in the country’s health sector. Internationally, the procedure can cost upwards of USD 20,000, often within a single week.
In contrast, Rwanda provides kidney transplant services under the community-based health insurance scheme (Mutuelle de Santé), allowing patients to receive comprehensive care throughout the year.
Dr. Sendegeya noted that international partners involved in the programme are required not only to provide services but also to train Rwandan specialists.
“We are confident that from January 2026, kidney transplants will be performed entirely by Rwandan doctors, without external assistance,” he said.
The frequency of kidney transplants has also increased. While procedures were initially conducted once every three months, they are now carried out monthly, with plans underway to begin weekly transplants from 2026.
As a result, patients no longer need to travel abroad to access these services.
{{Expanding the health workforce
}}
Rwanda has also embarked on an ambitious programme to quadruple the number of healthcare professionals. Previously, one doctor served approximately 1,000 people, compared to the national target of four doctors per 1,000 citizens.
Two years into implementation, the programme has reached 45 per cent of its target, with 1,522 students enrolled in medical training. The Ministry of Health has further expanded medical education by introducing 14 new training programmes, bringing the total to 25 across various specialisations.
{{Maternal and child health breakthroughs
}}
In 2025, Rwanda recorded another medical milestone when a fetus received a blood transfusion while still in the womb, an unprecedented procedure in the country, successfully performed using advanced technology.
Improved training for specialists in maternal and reproductive health has contributed to a decline in maternal mortality, which fell from 111 to 82 deaths per 100,000 live births within a year.
Additionally, referrals of women experiencing childbirth complications to tertiary hospitals decreased by 30 per cent in secondary teaching hospitals, reflecting improved capacity at lower-level facilities.
{{Cervical cancer elimination drive
}}
Rwanda is continuing its drive to eliminate cervical cancer by 2027, ahead of the World Health Organisation’s (WHO) global target of 2030.
The government estimates that achieving this goal will require an investment of USD 38.4 million. WHO targets include vaccinating 90 per cent of girls against the human papillomavirus (HPV), screening 70 per cent of women aged 30–49 using HPV DNA testing, and ensuring timely treatment for 90 per cent of women diagnosed with the disease.
Rwanda is on track to meet these benchmarks at least three years early. Plans indicate that 627,889 girls aged 12 will be vaccinated, 1,366,880 women aged 30–49 screened, and 6,277 women treated for cervical cancer.
Currently, screening coverage stands at 34 per cent. About 92 per cent of women diagnosed with early-stage cervical cancer recover following treatment, while 81 per cent of those with advanced disease receive modern care.
{{Emergency response and digital health
}}
Improved cancer care has gone hand in hand with strengthened emergency medical services. In Kigali, emergency responders now reach patients within 15 minutes of an incident.
Nationwide, the ambulance fleet has expanded to 510 vehicles, supporting referrals to higher-level hospitals and rapid response to accidents and acute illnesses.
These services are reinforced by the Health Intelligence Centre, launched in April 2025. The platform aggregates real-time data from health facilities across the country, enabling faster decision-making, improved oversight, and more efficient delivery of health services.
{{Investment in medical technology
}}
The health sector has also seen increased investment in modern diagnostic equipment, including sensor-based digital X-ray machines, 3D CT scanners, fluoroscopy systems for real-time organ imaging, mammography units for breast cancer screening, and ultrasound machines used in obstetrics and general diagnostics.
Among the most notable acquisitions is the ZEISS KINEVO 900 S surgical microscope at KF, the first of its kind in Rwanda, which enables surgeons to visualise minute anatomical structures and perform complex procedures with robotic assistance.
{{Nuclear medicine and pharmaceutical manufacturing
}}
Looking ahead, Rwanda is set to begin producing medical radionuclides in 2026 for use in advanced nuclear medicine. The country has already received preliminary authorisation to produce these substances, which are used in PET scans for precise diagnosis.
This move is expected to position Rwanda as a regional hub for nuclear medicine, reducing reliance on imports from Europe and Egypt.
In April 2025, Rwanda also inaugurated a medical syringe manufacturing plant in Rwamagana District. At full capacity, the facility is expected to produce between 600 million and one billion syringes per day, supplying both domestic demand and regional markets.
{{Disease surveillance and mental health care
}}
In November 2025, construction began on a USD 24 million laboratory dedicated to detecting zoonotic diseases transmitted from animals to humans. The facility is expected to be completed within two years.
Mental healthcare also advanced in 2025, with KFH introducing Ketamine therapy for severe mental health conditions, including treatment-resistant depression and acute post-traumatic stress disorder.
While traditionally used as an anaesthetic, Ketamine has been shown to produce rapid improvement in some psychiatric patients, often within hours.
This development comes amid rising demand for mental health services. Data from the Rwanda Biomedical Centre (RBC) show that, in 2022/2023, an average of 3,305 people were diagnosed with mental health-related conditions each month. CARAES Ndera Neuropsychiatric Hospital reported treating 119,859 patients in 2024/2025, a 17.7 per cent increase compared to the previous year.
